Fluorescein angiography
Fluorescein angiography is a medical device with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module
Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
Deep Learning for Fluorescein Angiography and Optical Coherence Tomography Macular Thickness Map Image Translation
Clinical Trials (8)
Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module
Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
Deep Learning for Fluorescein Angiography and Optical Coherence Tomography Macular Thickness Map Image Translation
Multimodal Imaging of Retinal Vessels
Establishment of Biomarkers for Fabry Disease
Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8